Susquehanna International Group
TFFP

Susquehanna International Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Susquehanna International Group’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-480
Closed -$5.64K – 13215
2023
Q2 		$5.64K Sell
480
-240
-33% -$3.45K ﹤0.01% 11816
2023
Q1 		$12.4K Buy
720
+240
+50% +$5.2K ﹤0.01% 12162
2022
Q4 		$12.6K Buy
+480
New +$22.8K ﹤0.01% 11890
2022
Q3 		– Sell
-2,612
Closed -$369K – 14323
2022
Q2 		$369K Buy
2,612
+248
+10% +$34.6K ﹤0.01% 8999
2022
Q1 		$373K Buy
2,364
+1,460
+162% +$236K ﹤0.01% 9721
2021
Q4 		$200K Sell
904
-280
-24% -$54.2K ﹤0.01% 11454
2021
Q3 		$229K Buy
1,184
+584
+97% +$124K ﹤0.01% 11192
2021
Q2 		$144K Sell
600
-1,364
-69% -$374K ﹤0.01% 11879
2021
Q1 		$666K Buy
+1,964
New +$799K ﹤0.01% 8789
2020
Q4 		– Sell
-2,868
Closed -$1.32M – 11858
2020
Q3 		$1.32M Buy
+2,868
New +$809K ﹤0.01% 5455

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's TFFP Position: Q4 2023 in Review

Susquehanna International Group sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 660 shares — an estimated $5.78K sold.

Susquehanna International Group first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $3.39M in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Susquehanna International Group reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 660 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $5.78K.
  • Susquehanna International Group first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Susquehanna International Group's TFF Pharmaceuticals, Inc. Common Stock position peaked at $3.39M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.